Search results
Results from the WOW.Com Content Network
The most recent COVID-19 vaccine should offer protection against the XEC variant, Russo says. “The most recent version of the vaccine seems to be reasonably well-matched,” he says.
As of September 2024, XEC, first found in Germany, is expected to be the next major variant. XEC is a recombination of two subvariants: KS.1.1 and KP.3.3. Only a few cases have been detected in the United States, [ 195 ] but it is reported to have a slight advantage over other variants in terms of transmissibility.
A study of samples collected in Manaus between November 2020 and January 2021, indicated that the Gamma variant is 1.4–2.2 times more transmissible and was shown to be capable of evading 25–61% of inherited immunity from previous coronavirus diseases, leading to the possibility of reinfection after recovery from an earlier COVID-19 ...
The COVID-19 pandemic was the third leading cause of death globally in 2020 and the second in 2021, according to a recent World Health Organization report.The almost 13 million lives lost during ...
The timeline of the COVID-19 pandemic lists the articles containing the chronology and epidemiology of SARS-CoV-2, [1] the virus that causes the coronavirus disease 2019 and is responsible for the COVID-19 pandemic. The first human cases of COVID-19 occurred in Wuhan, People's Republic of China, on or about 17 November 2019. [2]
As respiratory virus season approaches in the U.S., some are concerned about whether XEC could cause a fall surge, and if the new COVID-19 vaccines being rolled out will protect against it.
2023–2024 Brazil Oropouche fever: 2 [325] [326] [327] 2024 American dengue epidemic: 2024–present: Latin America and the Caribbean: Dengue virus: 8,186 [328] 2024 Kwango province malaria outbreak: 2024–present: Democratic Republic of the Congo: Malaria: 143 [329] HMPV outbreak in East Asia: 2024–present: East Asia: Human metapneumovirus ...
At the end of June, the CDC recommended that everyone ages 6 months and older receive the updated 2024-25 COVID-19 vaccine, which was tweaked based on the most dominant variants circulating this year.